146 related articles for article (PubMed ID: 9112574)
1. Analysis of the DCC tumor suppressor gene in testicular germ cell tumors: mutations and loss of expression.
Strohmeyer D; Langenhof S; Ackermann R; Hartmann M; Strohmeyer T; Schmidt B
J Urol; 1997 May; 157(5):1973-6. PubMed ID: 9112574
[TBL] [Abstract][Full Text] [Related]
2. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors.
Murty VV; Li RG; Houldsworth J; Bronson DL; Reuter VE; Bosl GJ; Chaganti RS
Oncogene; 1994 Nov; 9(11):3227-31. PubMed ID: 7936646
[TBL] [Abstract][Full Text] [Related]
3. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
4. [Expression and loss of heterozygosity of DCC gene in human lung cancer].
Zhang J; Ding F; Wang X
Zhonghua Yi Xue Za Zhi; 1995 Apr; 75(4):211-3, 254-5. PubMed ID: 7788550
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
6. [Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes].
Nonomura N; Imazu T; Harada Y; Nozawa M; Ono Y; Fukui T; Nishimura K; Okuyama A
Hinyokika Kiyo; 1999 Aug; 45(8):593-7. PubMed ID: 10500969
[TBL] [Abstract][Full Text] [Related]
7. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.
Gao X; Honn KV; Grignon D; Sakr W; Chen YQ
Cancer Res; 1993 Jun; 53(12):2723-7. PubMed ID: 8504411
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of selected tumor suppressor genes in human testicular germ cell tumors.
Vladusić T; Hrasćan R; Vrhovac I; Kruslin B; Gamulin M; Grgić M; Pećina-Slaus N; Franekić Colić J
Pathol Res Pract; 2010 Mar; 206(3):163-7. PubMed ID: 20092957
[TBL] [Abstract][Full Text] [Related]
9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
10. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues.
Reale MA; Hu G; Zafar AI; Getzenberg RH; Levine SM; Fearon ER
Cancer Res; 1994 Aug; 54(16):4493-501. PubMed ID: 8044801
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction.
Cho JH; Noguchi M; Ochiai A; Hirohashi S
Lab Invest; 1996 Apr; 74(4):835-41. PubMed ID: 8606493
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-beta expression in human testicular germ cell tumors.
Pais V; Leav I; Lau KM; Jiang Z; Ho SM
Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity of tumor suppressor genes in testis cancer.
Peng HQ; Bailey D; Bronson D; Goss PE; Hogg D
Cancer Res; 1995 Jul; 55(13):2871-5. PubMed ID: 7796415
[TBL] [Abstract][Full Text] [Related]
15. Somatic isoform of angiotensin I-converting enzyme in the pathology of testicular germ cell tumors.
Franke FE; Pauls K; Kerkman L; Steger K; Klonisch T; Metzger R; Alhenc-Gelas F; Burkhardt E; Bergmann M; Danilov SM
Hum Pathol; 2000 Dec; 31(12):1466-76. PubMed ID: 11150371
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
Kubo H; Miki C; Kusunoki M
Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue.
Yuasa T; Okamoto K; Kawakami T; Mishina M; Ogawa O; Okada Y
J Urol; 2001 May; 165(5):1790-4. PubMed ID: 11342977
[TBL] [Abstract][Full Text] [Related]
18. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis.
Miyake S; Nagai K; Yoshino K; Oto M; Endo M; Yuasa Y
Cancer Res; 1994 Jun; 54(11):3007-10. PubMed ID: 8187090
[TBL] [Abstract][Full Text] [Related]
19. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
[TBL] [Abstract][Full Text] [Related]
20. Expression of the tumor suppressor gene DCC in human gliomas.
Scheck AC; Coons SW
Cancer Res; 1993 Dec; 53(23):5605-9. PubMed ID: 8242611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
